Introduction
Evidence is accumulating to suggest that the dialysis encephalopathy syndrome is due to aluminium intoxication,' 2 arising primarily from aluminium contamination of the domestic water supply.3 I In the west of Scotland the incidence of dialysis encephalopathy has been confined to three regions where the aluminium concentration of the water supply is relatively high; no case has occurred in Glasgow, where aluminium concentrations in water are negligible.
We analysed the concentrations of aluminium and other elements in domestic water supplies in the west of Scotland dialysis area, and measured serum aluminium concentrations in patients receiving dialysis in this area.
Patients and methods
Samples of tap water (from which dialysis fluid is prepared) were collected from the homes of all patients receiving maintenance haemodialysis, from the homes of patients who had died of dialysis encephalopathy, and from the renal units of Stobhill General Hospital and the Royal Infirmary, Glasgow. Blood samples were obtained from all patients receiving dialysis, including five patients with dialysis encephalopathy. Stored serum samples from three further patients who had died of encephalopathy were also available. Control samples were obtained from 20 subjects with normal renal function and from 15 patients with chronic renal failure (mean serum creatinine concentration 1008 jimol/l (11.4 mg/100 ml)) who did not then need dialysis. Glasgow area, where no case of encephalopathy has occurred. No consistent difference was found in concentrations of the other elements measured, and we could not confirm the suggestion that manganese, calcium, or fluoride might also be implicated.4 Figure 1 shows the distribution of cases of encephalopathy in the west of Scotland dialysis area and the concentrations of aluminium in the water supply to the different areas. Comparison of the serum aluminium concentrations in the different populations studied (fig 2) showed that the highest values occurred in patients with dialysis encephalopathy, high values also being found in four patients who dialysed in suspect areas. Figure 3 shows a significant linear relation between concentrations of aluminium in serum and water.
Discussion
Our results provide further evidence to suggest that aluminium intoxication is the cause of the dialysis encephalopathy syndrome. The 13 patients with encephalopathy received home dialysis in three areas with a high aluminium content in the water supply. This is consistent with the observed geographical distribution; none of the 40 patients who dialysed in Glasgow, where the aluminium content of the water supply is negligible, developed encephalopathy. Alum (aluminium sulphate) is used as a coagulant to remove organic material from water and improve its clarity. Alum is added to most water supplies in the west of Scotland, with the exception of Glasgow, and it is the undoubted source of the high aluminium content in the water of the suspect areas.
All patients with greatly increased serum aluminium concentrations received home dialysis in areas with a high aluminium content in the water supply. The highest values were found in the eight patients with encephalopathy, from whom blood samples had been obtained at the onset of symptoms, and in four other patients who dialysed in suspect areas. These four patients did not have dialysis encephalopathy, but three of the four had symptoms or signs which we now think are premonitory features of dialysis encephalopathy-namely, general malaise, vomiting, weight loss, fall in haemoglobin concentration, and muscular or bony pains. The fourth patient received a cadaveric renal transplant shortly after his serum aluminium concentration was measured.
We observed an increased incidence of severe renal osteomalacic disease in our encephalopathic group. Four of the 13 patients (31°) developed symptoms and radiological appearances typical of osteomalacia, as compared with an incidence of about 10bo in the rest of our home dialysis population. This confirms the findings of other studies3 6 in which a more definite relation between bone disease, encephalopathy, and water supply is reported. We also observed that haemoglobin values in the encephalopathic patients fell during the year before neurological symptoms developed. A fall in haemoglobin was also seen in three of the four other patients with very high serum aluminium concentrations, and we have some preliminary evidence that aluminium may be toxic to the enzymes concerned in haem biosynthesis. 7
Our findings suggest that aluminium retention occurs in all patients with renal impairment. The ingestion of aluminium hydroxide may be a contributory factor, but the major source is the high aluminium content of the water supply from which dialysis fluid is prepared. The highest serum aluminium concentrations occurred acutely when patients were exposed to very high aluminium concentrations in water, and in our two most recent cases of dialysis encephalopathy the syndrome developed rapidly after the water aluminium content had of successful transplantation8 or by dialysis using a water purification system. We conclude that aluminium contamination of the water used for dialysis is the probable cause of dialysis encephalopathy. The resulting aluminium intoxication is not confined to the nervous system but is almost certainly a factor in causing bone disease and possibly also in aggravating anaemia. We reiterate the advice of others4 that all patients who dialyse in areas with a high concentration of aluminium in the water should use some form of water purification system, though this will not necessarily protect patients who have already accumulated large amounts of aluminium. At present the use of deionisers or reverse-osmosis apparatus may be the most effective method of extracting aluminium from the water, but more-specific techniques may be devised if it can be confirmed that aluminium is the only potential toxin in the supply to an area.
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Introduction
About half the calcium in serum is bound to protein or complexed. It is the other half, ionised and biologically active, that interests the clinician, but for the past 40 years only a few research laboratories have been able to measure it. Many of the teething troubles of the Orion SS-20 ionised calcium meter have now been surmounted, which has brought this measurement within the grasp of any hospital laboratory willing to devote to it sufficient capital, running costs, and technician time.1-'3 High demand for the measurement has led a few institutions like our own, with a strong interest in renal failure and parathyroid surgery, to make the investment; in the average district general hospital the demand will be much more modest. A decision to add another financial burden to the NHS will hinge on the reliability of the available alternatives, which in ascending order of complexity are (1) uncorrected total serum calcium concentration, (2) total serum calcium with serum protein or albumin for the clinician to make an "eyeball adjustment," (3) correction of total serum calcium concentration for protein or albumin by formula, and (4) prediction of ionised serum calcium from total calcium and protein or albumin by formula or nomogram.
"Correction" of the total serum calcium concentration has been a subject of much controversy during the past two years. Pain et all4 concluded that because of the large interindividual variation a tedious procedure was necessary to calculate the correction factor individually. On the other hand, the BM715 stated: "In specialised units newer methods for ionised calcium assay may prove valuable, but for most of us the 'corrected' plasma calcium is an adequate measure of ionised calcium on almost all occasions."
We therefore compared serum ionised calcium concentrations
